NASDAQ: CGON · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

CG Oncology Inc.

How CG Oncology Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$5.6B

Price

$63.47

P/E

-25.0

EPS (TTM)

$-2.54

1-year return

47.7%

Dividend yield

0.0%

52-week range

$40.71–$70.89

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources